GRAND JURY PROBES MERCK’S MARKETING OF VIOXX

GRAND JURY PROBES MERCK’S MARKETING OF VIOXX

GRAND JURY PROBES MERCK’S MARKETING OF VIOXX 150 150 Dan Frith

We have all heard about that wonderful drug, Vioxx, a miracle drug which effectively controlled pain allowing for a normal and full life. However, we soon learned that the drug also caused heart attacks and strokes….information kept from the consuming public.

The latest news is that Merck & Co., the drug’s manufacturer, has become the subject of a federal grand-jury probe into its sales and marketing practices for Vioxx, the painkiller it pulled from the market in 2004. The health-care-fraud unit of the U.S. Attorney’s Office for the District of Massachusetts is investigating whether Merck promoted Vioxx to health-care professionals for uses other than those approved by government regulators, a practice known as off-label marketing.

Merck, one of the largest pharmaceutical manufacturers in the world, has so far declined to comment on the report of the investigation.

Share
About the author

Dan Frith

Dan Frith has over 25 years of experience representing individuals and families in cases of medical malpractice throughout Virginia. He has been named "Best Medical Malpractice Attorney" by Roanoker Magazine and is a member of the Million Dollar Advocates Forum. To speak with Dan, contact him by email at dfrith@frithlawfirm.com.

Back to top